Macrophages as nanoparticle delivery vectors for photothermal therapy of brain tumors

Therapeutic Delivery

Volumn 6, Issue 3, 2015, Pages 371-384

  Christie, Catherine ^a,b   Madsen, Steen J ^c   Peng, Qian ^d   Hirschberg, Henry ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NEVADA   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD NANOPARTICLE; MACROGOL; NANOPARTICLE; NANOROD; NANOSHELL; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; GOLD; METAL NANOPARTICLE;

BRAIN TUMOR; CANCER INHIBITION; CANCER THERAPY; DRUG DELIVERY SYSTEM; HUMAN; MACROPHAGE; MONOCYTE; NEUROPATHOLOGY; NONHUMAN; PHAGOCYTOSIS; PHOTOTHERAPY; PHOTOTHERMAL THERAPY; PRIORITY JOURNAL; REVIEW; TUMOR SPHEROID; BRAIN NEOPLASMS; CELL MOTION; PHOTOCHEMOTHERAPY; PHYSIOLOGY; PROCEDURES;

BRAIN NEOPLASMS; CELL MOVEMENT; DRUG DELIVERY SYSTEMS; GOLD; HUMANS; MACROPHAGES; METAL NANOPARTICLES; PHAGOCYTOSIS; PHOTOCHEMOTHERAPY; PHOTOTHERAPY;

EID: 84927590262     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.14.121     Document Type: Review

References (67)

1. Fischbach MA, Bluestone JA, Lim WA. Cell-based therapeutics: the next pillar of medicine. Sci. Transl. Med. 5(179), ps7 (2013).
2. Basel MT, Shrestha TB, Bossmann SH, Troyer DL. Cells as delivery vehicles for cancer therapeutics. Ther. Deliv. 5(5), 555-567 (2014).
3. Maeda H. The enhanced permeability and retention effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41, 189-207 (2001).
4. Gonzalez-Mejia ME, Doseff AI. Regulation of monocytes and macrophages cell fate. Front. Biosci. (Landmark Ed.) 14, 2413-2431 (2009).
5. Badie B, Schartner JM. Flow cytometric characterization of tumor associated macrophages in experimental gliomas. Neurosurgery 46(4), 957-961 (2000).
6. Roggendorf W, Strupp S, Paulus W. Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol. 92, 288-293 (1996).
7. Strik HM, Stoll M, Meyermann R. Immune cell infiltration of intrinsic and metastatic intracranial tumours. Anticancer Res. 24, 37-42 (2004).
8. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest. Radiol. 39, 56-63 (2004).
9. Valable S, Barbier EL, Bernaudin M et al. In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma. Neuroimage 40(2), 973-983 (2008).
10. Choi MR, Stanton-Maxey KJ, Stanley JK et al. A cellular Trojan horse for delivery of therapeutic nanoparticles into tumors. Nano Lett. 7(12), 3759-3765 (2007).
11. Baek SK, Makkouk AR, Krasieva T, Sun CH, Madsen SJ, Hirschberg H. Photothermal treatment of glioma; an in vitro study of macrophage-mediated delivery of gold nanoshells. J. Neurooncol. 104(2), 439-448 (2011).
12. Basel MT, Balivada S, Wang H et al. Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. Int. J. Nanomedicine 7, 297-306 (2012).
13. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66(2), 605-612 (2006).
14. Hickey VF. Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 11, 125-137 (1999).
15. Fleige G, Nolte C, Synowitz M et al. Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 3, 489-499 (2001).
16. Petrecca K, Guiot MC, Panet-Raymond V et al. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with Glioblastoma. J. Neurooncol. 111, 19-23 (2013).
17. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation and clinical implications. Neurobiol. Dis. 16, 1-13 (2004).
18. Huber J, Egleton R, Davis T. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trend. Neurosci. 24, 719-725 (2001).
19. Abbott N. Physiology of the blood-brain barrier and its consequences for drug transport to the brain. International Congress Series 1277, 3-18 (2005).
20. Madsen SJ, Angell-Petersen A, Spetalen S, Carper SW, Ziegler SA, Hirschberg H. Photodynamic therapy of newly implanted glioma cells in the rat brain. Lasers Surg. Med. 38(5), 540-548 (2006).
21. Strik HM, Stoll M, Meyermann R. Immune cell infiltration of intrinsic and metastatic intracranial tumours. Anticancer Res. 24(1), 37-42 (2004).
22. Hirsch LR, Gobin AM, Lowery AR, Tam F, Jalas NJ. Metal nanoshells. Ann. Biomed. Eng. 334, 15-22 (2006).
23. Everts M. Thermal scalpel to target cancer. Expert Rev. Med. Devices 4(2), 131-136 (2007).
24. Loo C, Lin A, Hirsch L et al. Nanoshells-enabled photonicsbased imaging and therapy of cancer. Technol. Cancer Res. Treat. 3, 33-40 (2004).
25. Shanmugam V, Selvakumar S, Yeh CS. Near-infrared lightresponsive nanomaterials in cancer therapeutics. Chem. Soc. Rev. 43, 6254 (2014).
26. Oldenburg SJ, Averitt RD, Westcott SL. Nanoengineering of optical resonances. Chem. Phys. Lett. 288, 243-247 (1998).
27. Oldenburg SJ, Jackson JB, Westcott SL, Halas NJ. Infrared extinction properties of gold nanoshells. Appl. Phys. Lett. 75, 2897-2899 (1999).
28. Aslan K, Lakowicz J, Geddes CR. Plasmon light scattering in biology and medicine: new sensing approaches, visions and perspectives. Curr. Opin. Chem. Biol. 9, 538-544 (2005).
29. Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med. Sci. 23, 217-218 (2008).
30. Cole JR, Mirin NA, Knight MW, Goodrich GP, Halas NJ. Photothermal efficiencies of nanoshells and nanorods for clinical therapeutic applications. J. Phys. Chem. 113, 12090-12094 (2009).
31. Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 128, 2115-2120 (2006).
32. Thorek DL, Chen AK, Czupryna J, Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann. Biomed. Eng. 4, 23-38 (2006).
33. Weissleder R, Stark DD, Engelstad BL et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. Am. J. Roentgenol. 152(1), 167-173 (1989).
34. Weinstein JS, Varallyay CG, Dosa E et al. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J. Cereb. Blood Flow Metab. 30, 15-35 (2010).
35. Jordan A, Scholz R, Maier-Hauff K et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J. Neurooncol. 78(1), 7-14 (2006).
36. Maier-Hauff K, Rothe R, Scholz R et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J. Neurooncol. 81(1), 53-60 (2007).
37. Kah JC, Wong KY, Neoh KG et al. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study. J. Drug Target. 17, 181-193 (2009).
38. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur. Radiol. 14, 1851-1858 (2004).
39. Trinidad A, Hong SJ, Peng Q, Madsen SJ, Hirschberg H. Combined concurrent photodynamic and gold nanoshell loaded macrophage-mediated photothermal therapies: an in vitro study on squamous cell head and neck carcinoma. Lasers Surg. Med. 46(4), 310-318 (2014).
40. Chhetri S, Hirschberg H, Madsen SJ. Photothermal therapy of human glioma spheroids with gold-silica nanoshells and gold nanorods: a comparative study. Proceedings SPIE, Photonic Therapeutics & Diagnostics 8928(89280U), 1-8 (2014).
41. Kah JC, Wong KY, Neoh KG et al. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study. J. Drug Target 17(3), 181-193 (2009).
42. Owen MR, Byrne HM, Lewis CE. Mathematical modeling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites. J. Theor. Biol. 226, 377-391 (2004).
43. Madsen SJ, Sun CH, Tromberg BJ, Cristine V, De Magalhaes N, Hirschberg H. Multicell tumor spheroids in photodynamic therapy. Lasers Surg. Med. 38, 555-564 (2006).
44. Knowles HJ, Harris AL. Macrophages and the hypoxic tumour microenvironment. Front. Biosci. 12, 4298-4314 (2007).
45. Choi MR, Bardhan R, Stanton-Maxey KJ et al. Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse. Cancer Nanotechnol. 3, 1-6, 47-54 (2012).
46. Hirschberg H, Samset E, Hole PK, Lote K. Impact of intraoperative MRI on the results of surgery for high grade gliomas. Minim. Invasive Neurosurg. 48(2), 77-84 (2006).
47. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol. 7, 392-401 (2006).
48. Wu J, Yang S, Luo H, Zeng L, Ye L, Lu Y. Quantitative evaluation of monocyte transmigration into the brain following chemical opening of the blood-brain barrier in mice. Brain Res. 1098, 79-85 (2006).
49. Hirschberg H, Sun CH, Tromberg BJ, Yeh AT, Madsen SJ. Enhanced cytotoxic effects of 5- aminolevulinic acidmediated photodynamic therapy by concurrent hyperthermia in glioma spheroids. J. Neurooncol. 70, 289-299 (2004).
50. Hirschberg H, Zhang MJ, Gach HM et al. Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin. J. Neurooncol. 95(3), 317-329 (2009).
51. Madsen SJ, Sun CH, Tromberg BJ, Hirschberg H. Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy. Lasers Surg. Med. 29(5), 406-412 (2001).
52. Madsen SJ, Gach HM, Hong SJ, Uzal FA, Peng Q, Hirschberg H. Increased nanoparticle-loaded exogenous macrophage migration into the brain following PDT-induced blood-brain barrier disruption. Lasers Surg. Med. 45(8), 524-532 (2013).
53. Wust P, Hildebrandt B, Sreenivasa G et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 3(8), 487-497 (2002).
54. Valdagni R, Liu FF, Kapp DS. Important prognostic factors influencing outcome of combined radiation and hyperthermia. Int. J. Radiat. Biol. Phys. 15, 959-972 (1988).
55. Huilgol NG, Gupta S, Dixit R. Chemoradiation with hyperthermia in the treatment of head and neck cancer. Int. J. Hyperthermia 26(1), 21-25 (2010).
56. Dahl O. Mechanism of thermal enhancement of chemotherapeutic cytotoxicity. Hyperthermia & Oncology 4, 9-28 (1994).
57. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 217(3), 633-646 (2000).
58. Jolesz FA, Hynynen K. Magnetic resonance image-guided focused ultrasound surgery. Cancer J. 8(Suppl. 1), 100-112 (2002).
59. Schwartz JA, Shetty AM, Price RE et al. Feasibility study of particle-assisted laser ablation of brain tumors in orthotopic canine model. Cancer Res. 69, 1659-1667 (2009).
60. Johannesen TB, Watne K, Lote K et al. Intracavity fractionated balloon brachytherapy in glioblastoma. Acta Neurochir. (Wien). 141(2), 127-133 (1999).
61. Hirschberg H, Sun CH, Tromberg BJ, Yeh AT, Madsen SJ. Enhanced cytotoxic effects of 5- aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids. J. Neurooncol. 70, 289-299 (2004).
62. Yanase S, Nomura J, Matsumura Y et al. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia. Int. J. Oncol. 27(1), 193-201 (2005).
63. Kah JC, Wan RC, Wong KY, Mhaisalkar S, Sheppard CJ, Olivo M. Combinatorial treatment of photothermal therapy using gold nanoshells with conventional photodynamic therapy to improve treatment efficacy: an in vitro study. Lasers Surg. Med. 40(8), 584-589 (2008).
64. Kuo WS, Chang YT, Cho KC et al. Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy. Biomaterials 33(11), 3270-3278 (2012).
65. Kim JY, Choi WI, Kim M, Tae G. Tumor-targeting nanogel that can function independently for both photodynamic and photothermal therapy and its synergy from the procedure of PDT followed by PTT. J. Control Release 171(2), 113-121 (2013).
66. Chen R, Wang X, Yao X, Zheng X, Wang J, Jiang X. Near-IR-triggered photothermal/photodynamic dualmodality therapy system via chitosan hybrid nanospheres. Biomaterials 34(33), 8314-8322 (2013).
67. Prinsze C, Dubbelman TMAR, Van Steveninck J. Potentiation of the thermal inactivation of glyceraldehydes- 3-phosphate dehydrogenase by photodynamic treatment. A possible model for the synergistic interaction between photodynamic therapy and hyperthermia. Biochem. J. 276, 357-362 (1991).